Literature DB >> 15644339

Oligopeptidase B from Trypanosoma evansi. A parasite peptidase that inactivates atrial natriuretic factor in the bloodstream of infected hosts.

Rory E Morty1, Roger Pellé, István Vadász, Graciela L Uzcanga, Werner Seeger, José Bubis.   

Abstract

Serine oligopeptidases of trypanosomatids are emerging as important virulence factors and therapeutic targets in trypanosome infections. We report here the isolation and characterization of oligopeptidase B (OpdB) and its corresponding gene from Trypanosoma evansi, a pathogen of significant veterinary importance. The T. evansi opdB gene was present as a single copy per haploid genome containing an open reading frame of 2148 bp encoding a protein of 80.664 kDa. Purified OpdB hydrolyzed substrates with basic residues in P1 (k(cat)/K(m) for carbobenzyloxy-L-arginyl-L-arginyl-7-amido-4-methylcoumarin, 337 s(-1) x microm(-1)) and exhibited potent arginyl carboxypeptidase activity (k(cat)/K(m) for Val-Lys-Arg Arg-OH, 231 s(-1) x mM(-1)). While not secreted, T. evansi released OpdB into the plasma of infected hosts where it retained catalytic activity. Plasma OpdB levels correlated with blood parasitemia. In vitro, OpdB cleaved the peptide hormone atrial natriuretic factor (ANF) at four sites: Arg3 Arg4, Arg4 Ser5, Arg11 Ile12, and Arg27 Tyr28, thereby abrogating smooth muscle relaxant and prohypotensive properties of ANF. Circulating plasma ANF levels in T. evansi-infected rats were depressed from 130 to 8 pg x ml(-1), and plasma ANF levels inversely correlated with plasma OpdB activity. The in vitro half-life of ANF in rat plasma was reduced 300-fold in plasma from T. evansi-infected rodents, which contains high levels of OpdB activity. Addition of OpdB inhibitors to cell-free plasma from infected rodents significantly abrogated this ANF hydrolysis. Furthermore the in vivo ANF half-life was reduced 5-fold in T. evansi-infected rats. Thus, we propose a role for OpdB in peptide hormone dysregulation in trypanosomiasis, specifically in generating the depressed plasma levels of ANF in mammals infected with T. evansi.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15644339     DOI: 10.1074/jbc.M410066200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Host-parasite interactions in trypanosomiasis: on the way to an antidisease strategy.

Authors:  Nicolas Antoine-Moussiaux; Philippe Büscher; Daniel Desmecht
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

2.  Classico-molecular targeting of oligopeptidase B, cysteine protease and variable surface glycoprotein (VSG) genes of Trypanosoma evansi.

Authors:  Ruchi Singh Gaur; Vikrant Sudan; Amit Kumar Jaiswal; Amit Singh; Daya Shanker
Journal:  J Parasit Dis       Date:  2016-03-16

3.  Oligopeptidases B from Trypanossoma cruzi and Trypanossoma brucei inhibit inflammatory pain in mice by targeting serotoninergic receptors.

Authors:  Rafaela Quintanilha Abrahão; Adriano Cardoso Franciosi; Douglas Andrade; Luiz Juliano; Maria Aparecida Juliano; Renata Giorgi; Camila Squarzoni Dale
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

4.  Identification and characterization of cysteine proteinases of Trypanosoma evansi.

Authors:  S C Yadav; R Kumar; S Kumar; U Tatu; R K Singh; A K Gupta
Journal:  Parasitol Res       Date:  2011-02-25       Impact factor: 2.289

5.  Pyroglutamyl peptidase type I from Trypanosoma brucei: a new virulence factor from African trypanosomes that de-blocks regulatory peptides in the plasma of infected hosts.

Authors:  Rory E Morty; Patrick Bulau; Roger Pellé; Sherwin Wilk; Koji Abe
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

6.  Oligopeptidase B deficient mutants of Leishmania major.

Authors:  Jane C Munday; Karen McLuskey; Elaine Brown; Graham H Coombs; Jeremy C Mottram
Journal:  Mol Biochem Parasitol       Date:  2010-09-29       Impact factor: 1.759

7.  The oligopeptidase B of Leishmania regulates parasite enolase and immune evasion.

Authors:  Ryan K Swenerton; Shuyi Zhang; Mohammed Sajid; Katalin F Medzihradszky; Charles S Craik; Ben L Kelly; James H McKerrow
Journal:  J Biol Chem       Date:  2010-10-20       Impact factor: 5.157

8.  Proteomics of Trypanosoma evansi infection in rodents.

Authors:  Nainita Roy; Rishi Kumar Nageshan; Rani Pallavi; Harshini Chakravarthy; Syama Chandran; Rajender Kumar; Ashok Kumar Gupta; Raj Kumar Singh; Suresh Chandra Yadav; Utpal Tatu
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

9.  Evaluation of In Vitro Activity of Essential Oils against Trypanosoma brucei brucei and Trypanosoma evansi.

Authors:  Nathan Habila; Abel S Agbaji; Zakari Ladan; Isaac A Bello; Emmanuel Haruna; Monday A Dakare; Taofiq O Atolagbe
Journal:  J Parasitol Res       Date:  2010-03-28

10.  Oligopeptidase B from Leishmania amazonensis: molecular cloning, gene expression analysis and molecular model.

Authors:  Herbert Leonel de Matos Guedes; Monique Pacheco Duarte Carneiro; Daniel Cláudio de Oliveira Gomes; Bartira Rossi-Bergmann; Salvatore Giovanni De-Simone
Journal:  Parasitol Res       Date:  2007-09       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.